Lucid Diagnostics Inc. financial data

Symbol
LUCD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % -18.5%
Quick Ratio 2.54 %
Debt-to-equity 264 % +88.4%
Return On Equity -562 % -62.3%
Return On Assets -155 % -7.08%
Operating Margin -1.08K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.5M shares +24.2%
Common Stock, Shares, Outstanding 51.6M shares +21.9%
Entity Public Float 14.4M USD -23.8%
Common Stock, Value, Issued 52K USD +23.8%
Weighted Average Number of Shares Outstanding, Basic 50.4M shares +20.3%
Weighted Average Number of Shares Outstanding, Diluted 50.4M shares +20.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.19M USD +49.7%
Revenue from Contract with Customer, Excluding Assessed Tax 4.19M USD +49.7%
Cost of Revenue 369K USD
Research and Development Expense 6.46M USD -14.7%
Selling and Marketing Expense 16.9M USD -0.83%
General and Administrative Expense 18.5M USD -10.9%
Operating Income (Loss) -45.1M USD +13.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.8M USD +21%
Net Income (Loss) Attributable to Parent -44.8M USD +21%
Earnings Per Share, Basic -1.13 USD/shares +19.9%
Earnings Per Share, Diluted -1.13 USD/shares +26.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.5M USD -39.8%
Accounts Receivable, after Allowance for Credit Loss, Current 39K USD +85.7%
Inventory, Net 651K USD
Assets, Current 16.8M USD -38.4%
Property, Plant and Equipment, Net 940K USD -26.8%
Operating Lease, Right-of-Use Asset 2.86M USD +79.4%
Intangible Assets, Net (Excluding Goodwill) 842K USD -56.4%
Other Assets, Noncurrent 1.13M USD -0.18%
Assets 22.6M USD -32%
Accounts Payable, Current 1.14M USD +14.2%
Employee-related Liabilities, Current 1.18M USD +34%
Liabilities, Current 14.2M USD -52.9%
Operating Lease, Liability, Noncurrent 2.01M USD +333%
Liabilities 16.3M USD -47%
Retained Earnings (Accumulated Deficit) -192M USD -37.4%
Stockholders' Equity Attributable to Parent 6.34M USD +148%
Liabilities and Equity 22.6M USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -77.1%
Net Cash Provided by (Used in) Financing Activities 18.5M USD -23.4%
Net Cash Provided by (Used in) Investing Activities -37K USD -118%
Common Stock, Shares Authorized 300M shares +50%
Common Stock, Shares, Issued 51.6M shares +21.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.87M USD -65.6%
Deferred Tax Assets, Valuation Allowance 42.2M USD +62.2%
Deferred Tax Assets, Gross 42.2M USD +62.2%
Operating Lease, Liability 2.87M USD +80%
Depreciation 24K USD +700%
Payments to Acquire Property, Plant, and Equipment 17K USD -88.5%
Lessee, Operating Lease, Liability, to be Paid 3.23M USD +91.3%
Property, Plant and Equipment, Gross 2.1M USD +11.7%
Operating Lease, Liability, Current 855K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 979K USD +671%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.03M USD -11.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 363K USD +278%
Lessee, Operating Lease, Liability, to be Paid, Year Three 940K USD +1392%
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD +81.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 19K USD -20.8%
Operating Lease, Payments 305K USD +7.02%
Additional Paid in Capital 143M USD +10.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.09M USD -79.2%
Depreciation, Depletion and Amortization 501K USD -18.1%
Deferred Tax Assets, Net of Valuation Allowance 42.2M USD +62.2%
Share-based Payment Arrangement, Expense 4.33M USD -54.9%
Interest Expense 30K USD -99.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%